Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer
Open Access
- 1 May 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (5) , 505-509
- https://doi.org/10.1023/a:1008282412670
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Split-course accelerated therapy in head and neck cancer: An analysis of toxicityInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Very accelerated radiation therapy: Preliminary results in locally unresectable head and neck carcinomasInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunctionInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Head and Neck CancerNew England Journal of Medicine, 1993
- Overview of Combined Modality Therapies for Head and Neck CancerJNCI Journal of the National Cancer Institute, 1993
- Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and RadiotherapyNew England Journal of Medicine, 1992
- Use of radiation with or without WR-2721 in advanced rectal cancerCancer, 1992
- Clinical study of the radioprotective effects of amifostine (YM-08310, WR-2721) on chronic radiation injuryInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Prevention of Xerostomia-Related Dental Caries in Irradiated Cancer PatientsJournal of Dental Research, 1977
- Dental management of patients irradiated for oral cancerCancer, 1976